IGF2BP2 and ovarian carcinoma: Furthermore, we investigated the prognostic role of ALKBH5 and IGF2BP2 in ovarian cancer, which both showed the overexpression of ALKBH5 and IGF2BP2 represented the worse prognosis for ovarian cancer.